Hikma Pharmaceuticals USA Inc. recalls Lorazepam Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds
- Products
-
- Lorazepam Injection
- Where it was sold
-
Distributed Nationwide in the USA
Nationwide
- Units affected
- 382,775 1mL vials
- About this recall
- Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25